Variant report
Variant | esv3399349 |
---|---|
Chromosome Location | chr6:150302959-150307557 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ULBP1-1 | chr6:150302737-150304344 | l_3296_chr6:150302250-150304344_testes |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000111981 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9478331 | chr6:150303049-150303050 | Bivalent Enhancer | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs117800798 | chr6:150303054-150303055 | Bivalent Enhancer | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs563618623 | chr6:150303133-150303134 | Bivalent Enhancer | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs62442281 | chr6:150303141-150303142 | Bivalent Enhancer | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs549632335 | chr6:150303188-150303189 | Bivalent Enhancer | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs548671692 | chr6:150303205-150303206 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs4869782 | chr6:150303241-150303242 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs538806352 | chr6:150303252-150303253 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs566116073 | chr6:150303264-150303265 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs12196650 | chr6:150303348-150303349 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs572103827 | chr6:150303378-150303379 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs78568231 | chr6:150303386-150303387 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs534657229 | chr6:150303389-150303390 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs4870174 | chr6:150303401-150303402 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs537258284 | chr6:150303409-150303410 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs150140498 | chr6:150303424-150303425 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs9479321 | chr6:150303473-150303474 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs539553996 | chr6:150303499-150303500 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs145549356 | chr6:150303517-150303518 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs9479322 | chr6:150303566-150303567 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs9479323 | chr6:150303576-150303577 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs73614691 | chr6:150303599-150303600 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs181128373 | chr6:150303646-150303647 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs544299230 | chr6:150303688-150303689 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs544071207 | chr6:150303697-150303698 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs7773464 | chr6:150303710-150303711 | Inactive region | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | mRNA abundance |
27 | rs60373379 | chr6:150303765-150303766 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs546297624 | chr6:150303779-150303780 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs148853999 | chr6:150303789-150303790 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs9479324 | chr6:150303794-150303795 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs185621365 | chr6:150303834-150303835 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs562360256 | chr6:150303849-150303850 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs531284655 | chr6:150303867-150303868 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs67871424 | chr6:150303868-150303869 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs528568850 | chr6:150303893-150303894 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs6557232 | chr6:150303911-150303912 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs539131185 | chr6:150303944-150303945 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs561763717 | chr6:150303948-150303949 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs111564439 | chr6:150303954-150303955 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs10457078 | chr6:150303972-150303973 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs370636984 | chr6:150303977-150303978 | Bivalent Enhancer | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs554988285 | chr6:150304005-150304006 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs143488663 | chr6:150304063-150304064 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs115135007 | chr6:150304107-150304108 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs557637158 | chr6:150304115-150304116 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs10457856 | chr6:150304116-150304117 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs190497786 | chr6:150304178-150304179 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs538503153 | chr6:150304241-150304242 | Bivalent Enhancer Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs182730271 | chr6:150304242-150304243 | Bivalent Enhancer Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs187015261 | chr6:150304280-150304281 | Bivalent Enhancer Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 17417639 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:150302400-150303000 | Active TSS | Hela-S3 | cervix |
2 | chr6:150302800-150303000 | Bivalent/Poised TSS | H9 Cell Line | embryonic stem cell |
3 | chr6:150302800-150303000 | Bivalent Enhancer | Fetal Thymus | thymus |
4 | chr6:150303000-150303200 | Bivalent Enhancer | H9 Cell Line | embryonic stem cell |
5 | chr6:150303000-150303200 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
6 | chr6:150303000-150303200 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr6:150303800-150304000 | Bivalent Enhancer | Esophagus | oesophagus |
8 | chr6:150304200-150304400 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr6:150304200-150304600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr6:150304400-150304600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
11 | chr6:150304600-150304800 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
12 | chr6:150305600-150306200 | Bivalent Enhancer | Thymus | Thymus |
13 | chr6:150306400-150306600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
14 | chr6:150306600-150306800 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr6:150306600-150306800 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr6:150306600-150306800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
17 | chr6:150306600-150307000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr6:150306800-150307000 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr6:150306800-150307000 | Bivalent Enhancer | Colonic Mucosa | Colon |
20 | chr6:150307000-150307200 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
21 | chr6:150307000-150307200 | Bivalent Enhancer | HSMM | muscle |